F. Tripp-Villanueva - Concepedia

Author

F. Tripp-Villanueva

Centro Médico Nacional La Raza

Also Known As

F Tripp-Villanueva, F. Tripp-Villanueva, Francisco Tripp-Villanueva

Publications

168

Citations

H-Index

Concepts

All Affiliations

Centro Médico Nacional La Raza Mexican Social Security Institute Hospital de Especialidades Instituto Politécnico Nacional Tecnológico de Monterrey

About

F. Tripp-Villanueva is an author at Centro Médico Nacional La Raza specializing in hematology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	142
2	Immunology	6	6	113
3	Health Sciences	3	3	44
4	Cellular Therapies	3	3	50
5	Blood Transplantation	2	2	40

F. Tripp-Villanueva

Publications

159

Citations

H-Index

Page 1

	Year	Citations
Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Jorge Vela‐Ojeda, F. Tripp-Villanueva, Evelia Sánchez-Cortés, Archives of Medical Research Chronic Myeloid LeukemiaTransplantationMarrow TransplantationBone Marrow FailureStem Cell Transplantation	2000	29
Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant Jorge Vela‐Ojeda, F. Tripp-Villanueva, Evelia Sánchez-Cortés, Bone Marrow Transplantation TransplantationBlood TransfusionBone Marrow TransplantHematologySurgery	1999	29
Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation Jorge Vela‐Ojeda, Maria Esparza, Elba Reyes‐Maldonado, Annals of Hematology Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunology	2005	28
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization Jorge Vela‐Ojeda, F. Tripp-Villanueva, Laura Montiel‐Cervantes, Bone Marrow Transplantation ThrombosisStem Cell MobilizationImmunologyClinical TrialsHematology	2000	22
CD4 <sup>+</sup> CD25 <sup>+</sup> Lymphocyte and Dendritic Cell Mobilization with Intermediate Doses of Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Donors Jorge Vela‐Ojeda, Maria Esparza, Elba Reyes‐Maldonado, Stem Cells and Development	2005	17
Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced Intensity Versus Myeloablative Conditioning Regimens for the Treatment of Leukemia Jorge Vela‐Ojeda, Maria Esparza, F. Tripp-Villanueva, Stem Cells and Development Hematological MalignancyRic TransplantationChronic GvhdCell TherapyTransplantation	2004	12
Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma Jorge Vela‐Ojeda, Maria Esparza, Elba Reyes‐Maldonado, Annals of Hematology Hematological MalignancyLymphoid NeoplasiaDendritic Cell SubsetsPeripheral Blood MobilizationHematology	2006	12
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3 + and CD4 + lymphocytes Jorge Vela‐Ojeda, M. A. Garc�a-Ruiz Esparza, Elba Reyes‐Maldonado, Annals of Hematology Chronic Myeloid LeukemiaCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	2004	10

Page 1